Contact
searchSearch
HMP Global

Hair and Trichology

Featured

Alopecia
News
Upadacitinib Shows Consistent Efficacy Across Alopecia Areata Subgroups, Including Pediatric and JAK-Refractory Patients
03/31/2026
Riya Gandhi, MA
Meta-analysis reveals robust SALT improvements regardless of age, dose, or prior JAK inhibitor exposure.
Meta-analysis reveals robust SALT improvements regardless of age, dose, or prior JAK inhibitor exposure.
Meta-analysis reveals robust...
03/31/2026
The Dermatologist
oral medicine
News
Oral Supplementation Enhances Hair Strength and Collagen VII Expression in Patients With Hair Loss
03/31/2026
Riya Gandhi, MA
Combined nutraceutical formulation shows measurable improvements in hair resistance and structural biomarkers over 90 days.
Combined nutraceutical formulation shows measurable improvements in hair resistance and structural biomarkers over 90 days.
Combined nutraceutical...
03/31/2026
The Dermatologist
News
Upadacitinib Shows Promising Efficacy in Pediatric Refractory Alopecia Areata With Favorable Safety Profile
03/30/2026
Riya Gandhi, MA
Retrospective data suggest meaningful hair regrowth and tolerability in children with severe, treatment-resistant alopecia areata.
Retrospective data suggest meaningful hair regrowth and tolerability in children with severe, treatment-resistant alopecia areata.
Retrospective data suggest...
03/30/2026
The Dermatologist
alopecia areata
News
Upadacitinib Drives Robust Hair Regrowth in Adolescents and Adults With Severe Alopecia Areata
03/30/2026
Riya Gandhi, MA
Phase 3 subgroup analysis shows significant scalp and facial hair regrowth with upadacitinib, with consistent safety across age groups.
Phase 3 subgroup analysis shows significant scalp and facial hair regrowth with upadacitinib, with consistent safety across age groups.
Phase 3 subgroup analysis shows...
03/30/2026
The Dermatologist
alopecia areata
News
Study Highlights Patient-Driven Risk Tolerance for Ritlecitinib in Severe Alopecia Areata
01/16/2025
Jessica Garlewicz
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
A new analysis highlights the...
01/16/2025
The Dermatologist
alopecia areata
News
Impact of the Gut and Skin Microbiome in Alopecia
12/19/2023
Jessica Garlewicz
Researchers aimed to explore the current literature on the gut-skin connection in alopecia to summarize interventions that impact hair growth through modulation of the gut or skin microbiome.
Researchers aimed to explore the current literature on the gut-skin connection in alopecia to summarize interventions that impact hair growth through modulation of the gut or skin microbiome.
Researchers aimed to explore the...
12/19/2023
The Dermatologist
alopecia areata
News
Treatment Preferences of Adults and Adolescents With Alopecia Areata
12/19/2023
Jessica Garlewicz
Researchers aimed to gauge the treatment preferences of both adult (≥18 years) and adolescent (12–17 years) patients with alopecia areata in the United States and Europe.
Researchers aimed to gauge the treatment preferences of both adult (≥18 years) and adolescent (12–17 years) patients with alopecia areata in the United States and Europe.
Researchers aimed to gauge the...
12/19/2023
The Dermatologist
alopecia areata
News
Reflectance Confocal Microscopy and Dermoscopy: Insights Into Linear Alopecia in Pediatric Patients
12/12/2023
Jessica Garlewicz
Researchers aimed to enhance the diagnostic accuracy of alopecia areata, trichotillomania, nevus sebaceous, and linear scleroderma en coup de sabre, all of which can manifest as linear alopecia,
Researchers aimed to enhance the diagnostic accuracy of alopecia areata, trichotillomania, nevus sebaceous, and linear scleroderma en coup de sabre, all of which can manifest as linear alopecia,
Researchers aimed to enhance the...
12/12/2023
The Dermatologist
alopecia areata
News
Possible Association Between Genetically Predicted Rheumatoid Arthritis and Alopecia Areata
12/12/2023
Jessica Garlewicz
Researchers aimed to elucidate the potential causal relationship between rheumatoid arthritis and alopecia areata using the Mendelian randomization design.
Researchers aimed to elucidate the potential causal relationship between rheumatoid arthritis and alopecia areata using the Mendelian randomization design.
Researchers aimed to elucidate...
12/12/2023
The Dermatologist
alopecia areata
News
Clinical Benefits of Baricitinib Therapy in Patients With Severe Alopecia Areata
11/30/2023
Jessica Garlewicz
Researchers combined results from BRAVE-AA1 and BRAVE-AA2 clinical trials, investigating the impact of baricitinib treatment on scalp hair regrowth over 52 weeks.
Researchers combined results from BRAVE-AA1 and BRAVE-AA2 clinical trials, investigating the impact of baricitinib treatment on scalp hair regrowth over 52 weeks.
Researchers combined results...
11/30/2023
The Dermatologist
alopecia areata
News
Screening For Latent Infectious Disease in Patients With Alopecia Areata Before Using JAK Inhibitors
11/20/2023
Jessica Garlewicz
Researchers aimed to address the growing evidence supporting the efficacy of JAK inhibitors in treating alopecia areata.
Researchers aimed to address the growing evidence supporting the efficacy of JAK inhibitors in treating alopecia areata.
Researchers aimed to address the...
11/20/2023
The Dermatologist

Expert Insights

Dr Natasha Atanaskova Mesinkovska
Podcasts
Dr Natasha Atanaskova Mesinkovska on Alopecia Areata
05/16/2023
Natasha Atanaskova Mesinkovska, MD, PhD
In this exclusive interview, Dr Natasha Atanaskova Mesinkovska discussed her session on hair loss and treatment options for alopecia areata.
In this exclusive interview, Dr Natasha Atanaskova Mesinkovska discussed her session on hair loss and treatment options for alopecia areata.
In this exclusive interview, Dr...
05/16/2023
The Dermatologist
CH
Videos
How to Teach Families About Safe Hair Care for Skin of Color
01/17/2022
Candrice Heath, MD, FAAP, FAAD
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses...
01/17/2022
The Dermatologist
CH
Videos
Integrating Skin of Color Hair Care for Young Patients
01/09/2022
Candrice Heath, MD, FAAP, FAAD
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath,...
01/09/2022
The Dermatologist
Feature Story
Growing in Your Hair Practice
02/16/2021
Lauren Mateja
With the emphasis on emergent conditions and chronic disease management, dermatology sometimes overlooks the importance of hair. Patients who have seen a dermatologist may exhibit signs and symptoms of alopecia,...
With the emphasis on emergent conditions and chronic disease management, dermatology sometimes overlooks the importance of hair. Patients who have seen a dermatologist may exhibit signs and symptoms of alopecia,...
With...
02/16/2021
The Dermatologist
Feature Story
Treating Androgenetic Alopecia: A Review of Nonsurgical Options
07/15/2020
Androgenetic alopecia (AGA) is a common form of hair loss that affects an estimated 80 million Americans.1 In men, it can begin as early as the teen years and follows a characteristic pattern, and in women, AGA...
Androgenetic alopecia (AGA) is a common form of hair loss that affects an estimated 80 million Americans.1 In men, it can begin as early as the teen years and follows a characteristic pattern, and in women, AGA...
...
07/15/2020
The Dermatologist
Feature Story
Hair Loss Treatments: A Word of Caution
09/04/2008
More than 50% of the population of men in their 50s has cosmetically significant male pattern hair loss. No doubt, the pressure on individuals to look younger comes from all directions in our society.
More than 50% of the population of men in their 50s has cosmetically significant male pattern hair loss. No doubt, the pressure on individuals to look younger comes from all directions in our society.
More than 50% of the population...
09/04/2008
The Dermatologist
Saturday Morning Live
Podcasts
Hyperpigmentation Prevention and Treatment: Melasma, PIH, and Oral Tranexamic Acid
08/13/2026
Joseph F. Merola, MD, MMSc; Alice Bendix Gottlieb, MD, PhD
Dr Andrew Alexis (Weill Cornell Medicine) joins hosts Dr Alice Gottlieb and Dr Joseph Merola to break down a practical, stage-by-stage approach to hyperpigmentation in skin of color.
Dr Andrew Alexis (Weill Cornell Medicine) joins hosts Dr Alice Gottlieb and Dr Joseph Merola to break down a practical, stage-by-stage approach to hyperpigmentation in skin of color.
Dr Andrew Alexis (Weill Cornell...
08/13/2026
The Dermatologist
Asempa
Videos
Myth Buster: Shared Decision-Making is Easy in Alopecia Areata
08/06/2026
Oyetewa Boluwatito Asempa, MD, FAAD; Riya Gandhi, MA
Shared decision-making in alopecia areata is often more complex than it appears. Dr Oyetewa Asempa discusses aligning treatment goals, managing expectations, and improving patient-clinician communication.
Shared decision-making in alopecia areata is often more complex than it appears. Dr Oyetewa Asempa discusses aligning treatment goals, managing expectations, and improving patient-clinician communication.
Shared decision-making in...
08/06/2026
The Dermatologist
Draelos
Videos
Myth Buster: Hair Regrowth is the Only Outcome That Matters
08/06/2026
Zoe Diana Draelos, MD; Riya Gandhi, MA
Hair regrowth is only one measure of success in alopecia areata. Dr Zoe Draelos highlights patient-centered outcomes, quality of life, emotional well-being, and long-term disease control.
Hair regrowth is only one measure of success in alopecia areata. Dr Zoe Draelos highlights patient-centered outcomes, quality of life, emotional well-being, and long-term disease control.
Hair regrowth is only one...
08/06/2026
The Dermatologist
Draelos
Videos
Myth Buster: Children are More Resilient to Alopecia Areata Than Adults
08/06/2026
Zoe Diana Draelos, MD; Riya Gandhi, MA
Pediatric alopecia areata can have profound emotional and social consequences. Dr Zoe Draelos examines the unique psychological challenges facing children and adolescents with the disease.
Pediatric alopecia areata can have profound emotional and social consequences. Dr Zoe Draelos examines the unique psychological challenges facing children and adolescents with the disease.
Pediatric alopecia areata can...
08/06/2026
The Dermatologist
Draelos
Videos
Myth Buster: Patients Will Adjust to Alopecia Areata Over Time
08/06/2026
Zoe Diana Draelos, MD; Riya Gandhi, MA
Adapting to alopecia areata isn't always a linear process. Dr Zoe Draelos discusses the lasting emotional impact of the disease and why ongoing psychosocial support remains essential.
Adapting to alopecia areata isn't always a linear process. Dr Zoe Draelos discusses the lasting emotional impact of the disease and why ongoing psychosocial support remains essential.
Adapting to alopecia areata...
08/06/2026
The Dermatologist
Asempa
Videos
Myth Buster: Dermatologists are Already Addressing the Psychosocial Burden of Alopecia Areata
08/06/2026
Oyetewa Boluwatito Asempa, MD, FAAD; Riya Gandhi, MA
Treating alopecia areata extends beyond managing hair loss. Dr Oyetewa Asempa explores gaps in psychosocial care, patient communication, and integrating mental health into clinical practice.
Treating alopecia areata extends beyond managing hair loss. Dr Oyetewa Asempa explores gaps in psychosocial care, patient communication, and integrating mental health into clinical practice.
Treating alopecia areata extends...
08/06/2026
The Dermatologist
Guttman
Videos
Myth Buster: If Treatment is Working, Patients can Stop it Immediately
08/06/2026
Emma Guttman-Yassky, MD, PhD; Riya Gandhi, MA
Successful alopecia areata treatment doesn't always mean therapy should end. Dr Emma Guttman discusses relapse risk, maintenance strategies, and setting realistic expectations for long-term disease management.
Successful alopecia areata treatment doesn't always mean therapy should end. Dr Emma Guttman discusses relapse risk, maintenance strategies, and setting realistic expectations for long-term disease management.
Successful alopecia areata...
08/06/2026
The Dermatologist
Emma Guttman
Videos
Myth Buster: Once a Patient Loses all Their Hair, Treatment Won’t Work
08/06/2026
Emma Guttman-Yassky, MD, PhD; Riya Gandhi, MA
Complete hair loss doesn't necessarily mean treatment failure in alopecia areata. Examine the latest evidence on therapeutic response, severe disease, and evolving treatment strategies.
Complete hair loss doesn't necessarily mean treatment failure in alopecia areata. Examine the latest evidence on therapeutic response, severe disease, and evolving treatment strategies.
Complete hair loss doesn't...
08/06/2026
The Dermatologist
Guttman
Videos
Myth Buster: Alopecia Areata is Just Hair Loss
08/06/2026
Emma Guttman-Yassky, MD, PhD; Riya Gandhi, MA
Alopecia areata is more than hair loss. Dr Emma Guttman discusses the disease's psychosocial burden, autoimmune nature, and why viewing AA as purely cosmetic can undermine patient care.
Alopecia areata is more than hair loss. Dr Emma Guttman discusses the disease's psychosocial burden, autoimmune nature, and why viewing AA as purely cosmetic can undermine patient care.
Alopecia areata is more than...
08/06/2026
The Dermatologist
Craiglow
Videos
Myth Buster: Alopecia Areata is No Longer an Unmet Need in Dermatology
08/06/2026
Brittany Craiglow, MD; Riya Gandhi, MA
Despite major therapeutic advances, alopecia areata remains an area of unmet need. Dr Brittany Craiglow explores ongoing challenges in treatment access, research, and long-term disease management.
Despite major therapeutic advances, alopecia areata remains an area of unmet need. Dr Brittany Craiglow explores ongoing challenges in treatment access, research, and long-term disease management.
Despite major therapeutic...
08/06/2026
The Dermatologist

News

alopecia areata
News
Study Highlights Patient-Driven Risk Tolerance for Ritlecitinib in Severe Alopecia Areata
01/16/2025
Jessica Garlewicz
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
A new analysis highlights the...
01/16/2025
The Dermatologist
alopecia areata
News
Impact of the Gut and Skin Microbiome in Alopecia
12/19/2023
Jessica Garlewicz
Researchers aimed to explore the current literature on the gut-skin connection in alopecia to summarize interventions that impact hair growth through modulation of the gut or skin microbiome.
Researchers aimed to explore the current literature on the gut-skin connection in alopecia to summarize interventions that impact hair growth through modulation of the gut or skin microbiome.
Researchers aimed to explore the...
12/19/2023
The Dermatologist
alopecia areata
News
Treatment Preferences of Adults and Adolescents With Alopecia Areata
12/19/2023
Jessica Garlewicz
Researchers aimed to gauge the treatment preferences of both adult (≥18 years) and adolescent (12–17 years) patients with alopecia areata in the United States and Europe.
Researchers aimed to gauge the treatment preferences of both adult (≥18 years) and adolescent (12–17 years) patients with alopecia areata in the United States and Europe.
Researchers aimed to gauge the...
12/19/2023
The Dermatologist
alopecia areata
News
Reflectance Confocal Microscopy and Dermoscopy: Insights Into Linear Alopecia in Pediatric Patients
12/12/2023
Jessica Garlewicz
Researchers aimed to enhance the diagnostic accuracy of alopecia areata, trichotillomania, nevus sebaceous, and linear scleroderma en coup de sabre, all of which can manifest as linear alopecia,
Researchers aimed to enhance the diagnostic accuracy of alopecia areata, trichotillomania, nevus sebaceous, and linear scleroderma en coup de sabre, all of which can manifest as linear alopecia,
Researchers aimed to enhance the...
12/12/2023
The Dermatologist
alopecia areata
News
Possible Association Between Genetically Predicted Rheumatoid Arthritis and Alopecia Areata
12/12/2023
Jessica Garlewicz
Researchers aimed to elucidate the potential causal relationship between rheumatoid arthritis and alopecia areata using the Mendelian randomization design.
Researchers aimed to elucidate the potential causal relationship between rheumatoid arthritis and alopecia areata using the Mendelian randomization design.
Researchers aimed to elucidate...
12/12/2023
The Dermatologist
alopecia areata
News
Clinical Benefits of Baricitinib Therapy in Patients With Severe Alopecia Areata
11/30/2023
Jessica Garlewicz
Researchers combined results from BRAVE-AA1 and BRAVE-AA2 clinical trials, investigating the impact of baricitinib treatment on scalp hair regrowth over 52 weeks.
Researchers combined results from BRAVE-AA1 and BRAVE-AA2 clinical trials, investigating the impact of baricitinib treatment on scalp hair regrowth over 52 weeks.
Researchers combined results...
11/30/2023
The Dermatologist
alopecia areata
News
Screening For Latent Infectious Disease in Patients With Alopecia Areata Before Using JAK Inhibitors
11/20/2023
Jessica Garlewicz
Researchers aimed to address the growing evidence supporting the efficacy of JAK inhibitors in treating alopecia areata.
Researchers aimed to address the growing evidence supporting the efficacy of JAK inhibitors in treating alopecia areata.
Researchers aimed to address the...
11/20/2023
The Dermatologist
alopecia areata
News
Utilizing Autologous Adipose Tissue Injection in Alopecia Treatment
11/17/2023
Jessica Garlewicz
Researchers aimed to explore the potential benefits of autologous adipose tissue injection, in the treatment of both scarring and nonscarring alopecia.
Researchers aimed to explore the potential benefits of autologous adipose tissue injection, in the treatment of both scarring and nonscarring alopecia.
Researchers aimed to explore the...
11/17/2023
The Dermatologist
alopecia areata
News
Association Between Zinc Deficiency and Alopecia Areata
11/16/2023
Jessica Garlewicz
Zinc is a crucial element for DNA stability and repair and plays a role in maintaining normal hair growth.
Zinc is a crucial element for DNA stability and repair and plays a role in maintaining normal hair growth.
Zinc is a crucial element for...
11/16/2023
The Dermatologist
alopecia areata
News
Links Between Alopecia Areata and Auditory Dysfunction
10/23/2023
Jessica Garlewicz
Researchers aimed to investigate the link between alopecia areata and hearing problems.
Researchers aimed to investigate the link between alopecia areata and hearing problems.
Researchers aimed to investigate...
10/23/2023
The Dermatologist
FDA Alerts
FDA Grants Accelerated Approval to Tudriqev for PD-1-Refractory Advanced Melanoma
08/07/2026
Jessica Garlewicz
The US Food and Drug Administration (FDA) has granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg) in combination with nivolumab for the treatment of adults with unresectable advanced cutaneous melanoma.
The US Food and Drug Administration (FDA) has granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg) in combination with nivolumab for the treatment of adults with unresectable advanced cutaneous melanoma.
The US Food and Drug...
08/07/2026
The Dermatologist
roflum
FDA Alerts
FDA Approves Roflumilast Cream 0.3% for Plaque Psoriasis in Children as Young as 2 Years
06/30/2026
Riya Gandhi, MA
The expanded indication makes roflumilast cream 0.3% the first once-daily, steroid-free topical therapy approved for plaque psoriasis in children aged 2 years and older, providing a new long-term treatment option for pediatric patients.
The expanded indication makes roflumilast cream 0.3% the first once-daily, steroid-free topical therapy approved for plaque psoriasis in children aged 2 years and older, providing a new long-term treatment option for pediatric patients.
The expanded indication makes...
06/30/2026
The Dermatologist
FDA Alert
FDA Alerts
FDA Approves Every-8-Week Maintenance Dosing Option for Lebrikizumab in Atopic Dermatitis
06/10/2026
Jessica Garlewicz
The FDA approved an every-8-week maintenance dosing regimen for Ebglyss (lebrikizumab-lbkz), providing a new administration option for adults and adolescents aged 12 years and older weighing at least 40 kg with moderate-to-severe atopic...
The FDA approved an every-8-week maintenance dosing regimen for Ebglyss (lebrikizumab-lbkz), providing a new administration option for adults and adolescents aged 12 years and older weighing at least 40 kg with moderate-to-severe atopic...
The FDA approved an every-8-week...
06/10/2026
The Dermatologist
psoriasis0
News
Altered Lysine Crotonylation Identified in Psoriatic Skin
03/19/2026
Jessica Garlewicz
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a...
03/19/2026
The Dermatologist
FDA Alerts
FDA Approves Icotyde (icotrokinra) for the Treatment of Moderate-To-Severe Plaque Psoriasis in Adults and Pediatric Patients
03/18/2026
Jessica Garlewicz
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug...
03/18/2026
The Dermatologist
FDA Alerts
FDA Approves Cosentyx for the Treatment of Pediatric Patients Aged 12 Years and Older With Moderate-To-Severe Hidradenitis Suppurativa
03/17/2026
Jessica Garlewicz
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug...
03/17/2026
The Dermatologist
AD
News
Mixed Associations Between Socioeconomic Status and Pediatric Atopic Dermatitis Highlight Research Gaps
03/11/2026
Jessica Garlewicz
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to...
03/11/2026
The Dermatologist
FDA Alerts
FDA Approves Sotyktu for the Treatment of Adults with Active Psoriatic Arthritis
03/10/2026
Jessica Garlewicz
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food...
03/10/2026
The Dermatologist
random
News
Biologic Therapy Improves Psychological Well-Being and Quality of Life in Psoriasis
03/03/2026
Jessica Garlewicz
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for...
03/03/2026
The Dermatologist
psoriasis
News
Low Prevalence but Meaningful Impact of Psychological Symptoms Seen in Well-Controlled Psoriasis
02/03/2026
Jessica Garlewicz
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms...
02/03/2026
The Dermatologist

Quizzes and Polls

Quiz
Trivia: Alopecia Areata
03/29/2019
Which finding is common among patients with alopecia areata affecting the nails?
Which finding is common among patients with alopecia areata affecting the nails?
Which finding is common among...
03/29/2019
The Dermatologist
AD
Quiz
Pediatric AD Quiz: Biologic Therapy Challenges in Children
08/10/2026
Riya Gandhi, MA
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of...
08/10/2026
The Dermatologist
AD
Quiz
Pediatric AD Quiz: When to Escalate to Systemic Therapy
08/10/2026
Riya Gandhi, MA
Test your knowledge of treatment escalation in pediatric atopic dermatitis. This clinical quiz explores when topical therapy is no longer sufficient and when to initiate systemic treatment in children.
Test your knowledge of treatment escalation in pediatric atopic dermatitis. This clinical quiz explores when topical therapy is no longer sufficient and when to initiate systemic treatment in children.
Test your knowledge of treatment...
08/10/2026
The Dermatologist
Quiz
Type 2 Endotypes and Therapeutic Strategy in Prurigo Nodularis
06/25/2026
Riya Gandhi, MA
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type...
06/25/2026
The Dermatologist
itch
Quiz
Fibrosis and Persistent Itch in Prurigo Nodularis
06/15/2026
Riya Gandhi, MA
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding...
06/15/2026
The Dermatologist
brain
Quiz
Neuroimmune Mechanisms and Cytokine Signaling in Prurigo Nodularis
06/05/2026
Riya Gandhi, MA
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in...
06/05/2026
The Dermatologist
Quiz
Predicting Disease Severity and Persistence in Pediatric Atopic Dermatitis
04/15/2026
Riya Gandhi, MA
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in...
04/15/2026
The Dermatologist
Quiz
Type 2 Inflammation and Early Systemic Therapy in Pediatric Atopic Dermatitis
04/05/2026
Riya Gandhi, MA
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical...
04/05/2026
The Dermatologist
Quiz
Disease Heterogeneity in PN
03/15/2026
Riya Gandhi, MA
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of...
03/15/2026
The Dermatologist
Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
Quiz
Cytokine Hierarchy and Sustained Pruritus in PN
03/10/2026
Riya Gandhi, MA
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and...
03/10/2026
The Dermatologist
July/August 2026

Current Issue

August 2026
Volume 34
Issue 5
Current Issue
Issue Archive

Recent News

alopecia areata
News
Study Highlights Patient-Driven Risk Tolerance for Ritlecitinib in Severe Alopecia Areata
01/16/2025
Jessica Garlewicz
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
A new analysis highlights the...
01/16/2025
The Dermatologist
alopecia areata
News
Impact of the Gut and Skin Microbiome in Alopecia
12/19/2023
Jessica Garlewicz
Researchers aimed to explore the current literature on the gut-skin connection in alopecia to summarize interventions that impact hair growth through modulation of the gut or skin microbiome.
Researchers aimed to explore the current literature on the gut-skin connection in alopecia to summarize interventions that impact hair growth through modulation of the gut or skin microbiome.
Researchers aimed to explore the...
12/19/2023
The Dermatologist
alopecia areata
News
Treatment Preferences of Adults and Adolescents With Alopecia Areata
12/19/2023
Jessica Garlewicz
Researchers aimed to gauge the treatment preferences of both adult (≥18 years) and adolescent (12–17 years) patients with alopecia areata in the United States and Europe.
Researchers aimed to gauge the treatment preferences of both adult (≥18 years) and adolescent (12–17 years) patients with alopecia areata in the United States and Europe.
Researchers aimed to gauge the...
12/19/2023
The Dermatologist
alopecia areata
News
Reflectance Confocal Microscopy and Dermoscopy: Insights Into Linear Alopecia in Pediatric Patients
12/12/2023
Jessica Garlewicz
Researchers aimed to enhance the diagnostic accuracy of alopecia areata, trichotillomania, nevus sebaceous, and linear scleroderma en coup de sabre, all of which can manifest as linear alopecia,
Researchers aimed to enhance the diagnostic accuracy of alopecia areata, trichotillomania, nevus sebaceous, and linear scleroderma en coup de sabre, all of which can manifest as linear alopecia,
Researchers aimed to enhance the...
12/12/2023
The Dermatologist
alopecia areata
News
Possible Association Between Genetically Predicted Rheumatoid Arthritis and Alopecia Areata
12/12/2023
Jessica Garlewicz
Researchers aimed to elucidate the potential causal relationship between rheumatoid arthritis and alopecia areata using the Mendelian randomization design.
Researchers aimed to elucidate the potential causal relationship between rheumatoid arthritis and alopecia areata using the Mendelian randomization design.
Researchers aimed to elucidate...
12/12/2023
The Dermatologist
alopecia areata
News
Clinical Benefits of Baricitinib Therapy in Patients With Severe Alopecia Areata
11/30/2023
Jessica Garlewicz
Researchers combined results from BRAVE-AA1 and BRAVE-AA2 clinical trials, investigating the impact of baricitinib treatment on scalp hair regrowth over 52 weeks.
Researchers combined results from BRAVE-AA1 and BRAVE-AA2 clinical trials, investigating the impact of baricitinib treatment on scalp hair regrowth over 52 weeks.
Researchers combined results...
11/30/2023
The Dermatologist
alopecia areata
News
Screening For Latent Infectious Disease in Patients With Alopecia Areata Before Using JAK Inhibitors
11/20/2023
Jessica Garlewicz
Researchers aimed to address the growing evidence supporting the efficacy of JAK inhibitors in treating alopecia areata.
Researchers aimed to address the growing evidence supporting the efficacy of JAK inhibitors in treating alopecia areata.
Researchers aimed to address the...
11/20/2023
The Dermatologist
alopecia areata
News
Utilizing Autologous Adipose Tissue Injection in Alopecia Treatment
11/17/2023
Jessica Garlewicz
Researchers aimed to explore the potential benefits of autologous adipose tissue injection, in the treatment of both scarring and nonscarring alopecia.
Researchers aimed to explore the potential benefits of autologous adipose tissue injection, in the treatment of both scarring and nonscarring alopecia.
Researchers aimed to explore the...
11/17/2023
The Dermatologist
alopecia areata
News
Association Between Zinc Deficiency and Alopecia Areata
11/16/2023
Jessica Garlewicz
Zinc is a crucial element for DNA stability and repair and plays a role in maintaining normal hair growth.
Zinc is a crucial element for DNA stability and repair and plays a role in maintaining normal hair growth.
Zinc is a crucial element for...
11/16/2023
The Dermatologist
alopecia areata
News
Links Between Alopecia Areata and Auditory Dysfunction
10/23/2023
Jessica Garlewicz
Researchers aimed to investigate the link between alopecia areata and hearing problems.
Researchers aimed to investigate the link between alopecia areata and hearing problems.
Researchers aimed to investigate...
10/23/2023
The Dermatologist
FDA Alerts
FDA Grants Accelerated Approval to Tudriqev for PD-1-Refractory Advanced Melanoma
08/07/2026
Jessica Garlewicz
The US Food and Drug Administration (FDA) has granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg) in combination with nivolumab for the treatment of adults with unresectable advanced cutaneous melanoma.
The US Food and Drug Administration (FDA) has granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg) in combination with nivolumab for the treatment of adults with unresectable advanced cutaneous melanoma.
The US Food and Drug...
08/07/2026
The Dermatologist
roflum
FDA Alerts
FDA Approves Roflumilast Cream 0.3% for Plaque Psoriasis in Children as Young as 2 Years
06/30/2026
Riya Gandhi, MA
The expanded indication makes roflumilast cream 0.3% the first once-daily, steroid-free topical therapy approved for plaque psoriasis in children aged 2 years and older, providing a new long-term treatment option for pediatric patients.
The expanded indication makes roflumilast cream 0.3% the first once-daily, steroid-free topical therapy approved for plaque psoriasis in children aged 2 years and older, providing a new long-term treatment option for pediatric patients.
The expanded indication makes...
06/30/2026
The Dermatologist
FDA Alert
FDA Alerts
FDA Approves Every-8-Week Maintenance Dosing Option for Lebrikizumab in Atopic Dermatitis
06/10/2026
Jessica Garlewicz
The FDA approved an every-8-week maintenance dosing regimen for Ebglyss (lebrikizumab-lbkz), providing a new administration option for adults and adolescents aged 12 years and older weighing at least 40 kg with moderate-to-severe atopic...
The FDA approved an every-8-week maintenance dosing regimen for Ebglyss (lebrikizumab-lbkz), providing a new administration option for adults and adolescents aged 12 years and older weighing at least 40 kg with moderate-to-severe atopic...
The FDA approved an every-8-week...
06/10/2026
The Dermatologist
psoriasis0
News
Altered Lysine Crotonylation Identified in Psoriatic Skin
03/19/2026
Jessica Garlewicz
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a...
03/19/2026
The Dermatologist
FDA Alerts
FDA Approves Icotyde (icotrokinra) for the Treatment of Moderate-To-Severe Plaque Psoriasis in Adults and Pediatric Patients
03/18/2026
Jessica Garlewicz
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug...
03/18/2026
The Dermatologist
FDA Alerts
FDA Approves Cosentyx for the Treatment of Pediatric Patients Aged 12 Years and Older With Moderate-To-Severe Hidradenitis Suppurativa
03/17/2026
Jessica Garlewicz
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug...
03/17/2026
The Dermatologist
AD
News
Mixed Associations Between Socioeconomic Status and Pediatric Atopic Dermatitis Highlight Research Gaps
03/11/2026
Jessica Garlewicz
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to...
03/11/2026
The Dermatologist
FDA Alerts
FDA Approves Sotyktu for the Treatment of Adults with Active Psoriatic Arthritis
03/10/2026
Jessica Garlewicz
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food...
03/10/2026
The Dermatologist
random
News
Biologic Therapy Improves Psychological Well-Being and Quality of Life in Psoriasis
03/03/2026
Jessica Garlewicz
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for...
03/03/2026
The Dermatologist
psoriasis
News
Low Prevalence but Meaningful Impact of Psychological Symptoms Seen in Well-Controlled Psoriasis
02/03/2026
Jessica Garlewicz
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms...
02/03/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use